Results 221 to 230 of about 207,533 (298)

Glucocorticoid‐Induced Hyperglycaemia in Hospital: The Insulin Dose Matters Most

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Prescription of glucocorticoids in hospital is a common cause of new onset hyperglycaemia, which is associated with increased mortality and morbidity. However, to date studies have not defined optimal treatment of hyperglycaemia associated with glucocorticoids and this is reflected in clinical guidelines.
Morton G. Burt   +3 more
wiley   +1 more source

Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia Gravis.

open access: yesJAMA Netw Open
Lord J   +10 more
europepmc   +1 more source

Low Risk of Central Nervous System Relapse Among Patients With T‐Cell/Histiocyte‐Rich Large B‐Cell Lymphoma Despite High‐Risk Disease Presentation

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT T‐cell/histiocyte‐rich large B‐cell lymphoma (THRLBCL) is a rare subtype of large B‐cell lymphoma (LBCL) for which central nervous system (CNS) relapse remains a devastating complication. The CNS International Prognostic Index (IPI) is usually used to predict the risk of CNS relapse. However, the overall risk of CNS relapse among patients with
Atte Karhu   +22 more
wiley   +1 more source

Systemic Low Dose Corticosteroid Improves Early Postoperative Knee Function and Pain Intensity in Patients Undergoing Unilateral Total Knee Arthroplasty: A Blinded Controlled Randomized Clinical Trial. [PDF]

open access: yesJB JS Open Access
Ebrahimzadeh MH   +10 more
europepmc   +1 more source

A case of propylthiouracil induced antineutrophil cytoplasmic antibody associated vasculopathy

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nikhil Dwivedi   +2 more
wiley   +1 more source

Bringing Gene Therapy Into Real World Clinical Practice

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Adeno‐associated virus (AAV)‐based gene therapy for haemophilia has shifted therapeutic paradigms by enabling hepatic gene transfer, restoring endogenous clotting factor expression, and reducing reliance on conventional prophylactic treatments. Two products, valoctocogene roxaparvovec (haemophilia A) and etranacogene dezaparvovec (
Wolfgang Miesbach   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy